Vident Advisory’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$579K Sell
7,594
-382
-5% -$29.3K ﹤0.01% 1286
2026
Q1
$645K Sell
7,976
-1,150
-13% -$95.8K 0.01% 1119
2025
Q4
$697K Sell
9,126
-1,401
-13% -$107K 0.01% 979
2025
Q3
$837K Sell
10,527
-929
-8% -$69.5K 0.01% 914
2025
Q2
$803K Sell
11,456
-1,235
-10% -$90.5K 0.01% 822
2025
Q1
$938K Buy
12,691
+201
+2% +$14.2K 0.01% 749
2024
Q4
$866K Sell
12,490
-3,525
-22% -$268K 0.02% 692
2024
Q3
$1.35M Buy
16,015
+65
+0.4% +$5.01K 0.03% 527
2024
Q2
$1.08M Buy
15,950
+2,576
+19% +$165K 0.03% 568
2024
Q1
$840K Buy
13,374
+1,007
+8% +$56.8K 0.02% 638
2023
Q4
$691K Buy
12,367
+1,210
+11% +$64.1K 0.02% 668
2023
Q3
$573K Buy
+11,157
New +$584K 0.02% 660

Other funds holding NHI

Vident Advisory's NHI Position: Q2 2026 in Review

Vident Advisory reduced its National Health Investors (NHI) stake by 4.8% in Q2 2026, selling an estimated $29.3K and leaving 7,594 shares worth $579K. The position accounts for ﹤0.01% of the portfolio, ranked #1286.

Vident Advisory first reported a position in NHI in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.35M in Q3 2024. 303 funds tracked by Wall St. Rank hold NHI as of Q2 2026.

  • Vident Advisory held 7,594 shares of National Health Investors worth $579K as of Q2 2026.
  • Vident Advisory sold 382 National Health Investors shares in Q2 2026, an estimated $29.3K.
  • National Health Investors made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1286 holding.
  • Vident Advisory first reported a position in National Health Investors in Q3 2023 and has held it in 12 quarters since.
  • Vident Advisory's National Health Investors position peaked at $1.35M in Q3 2024.
  • 303 funds tracked by Wall St. Rank held National Health Investors as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.